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Background: Ketamine, an N-methyl-D-aspartate receptor antagonist, can suppress hyperal-
gesia and allodynia. The purpose of the present study was to evaluate the clinical efficacy of 
preincisional intravenous or subcutaneous infiltration of ketamine for postoperative pain relief 
after appendectomy.
Methods: Ninety patients, aged 18–60 years, scheduled for appendectomy was enrolled in this 
study. Patients were divided into three groups of 30 each and received subcutaneous infiltration 
of ketamine 0.5 mg/kg (KS), intravenous ketamine 0.5 mg/kg (KI), or subcutaneous infiltra-
tion of normal saline 3 mL (C) before surgery. Visual analog scale (VAS) values and analgesic 
consumption were evaluated for 24 hours after surgery.
Results: VAS scores were significantly lower at the time of arrival in the recovery room, 
and at 10, 20, and 30 minutes thereafter in group KI and group KS compared with group C 
(P , 0.05). VAS scores were not significantly different between group KI and group KS at 
these intervals. Postoperative VAS scores were significantly lower at 6, 12, 18, and 24 hours in 
group KI compared with group C (P , 0.05). In group KS, the postoperative VAS score was 
significantly lower at 6 hours (P , 0.05). VAS scores were significantly lower at 12, 18, and 
24 hours after surgery in group KI compared with group KS (P , 0.05).
Conclusion: A 0.5 mg/kg dose of ketamine given at approximately 15 minutes before surgery 
by the intravenous route provided analgesia for 24 hours after surgery in patients undergoing 
appendectomy.
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Introduction
The most important factor related to patient discomfort after surgery is pain. Although 
many studies1,2 have shown that effective analgesia reduces postoperative complica-
tions, pain is often overlooked and not adequately controlled.3 It has been shown that 
many excitatory substances are released by painful impulses which stimulate receptors 
to cause pain.3,4 The principal phenomenon in inflammatory pain transmission is sen-
sitization of the spinal cord, with an active contribution from glutamate and aspartate 
amino acids at the N-methyl-dimethyl-aspartate (NMDA) receptor.4
Tan et al5 showed that preincisional treatment with subcutaneous infiltration of 
ketamine decreased the pain score after circumcision surgery. It seems reasonable 
to assume that peripheral pretreatment with ketamine may be a useful method for 
preventing postoperative pain in some other minor surgeries, such as appendectomy. 
Therefore, we designed this randomized, double-blind, prospective, placebo-controlled 
study to evaluate the analgesic effect of preincisional subcutaneous infiltration of 
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ketamine after appendectomy. To investigate the central and 
peripheral effects of subcutaneous infiltration of ketamine, 
it was necessary to include an additional group of patients 
who were administered intravenous ketamine at a similar 
dose. The analgesic effect of subcutaneous ketamine was 
also compared with that of intravenous ketamine.
Materials and methods
Ninety patients with American Society of Anesthesiologists 
physical status I–II, aged 18–60 years, and scheduled for 
appendectomy, gave their written informed consent to par-
ticipate in this study, which was approved by our institutional 
ethics committee. All patients were candidates for appendec-
tomy because appendicitis was not resolved by conservative 
treatment. No patients had abscess or perforation.
Patients with a known history of hypertension, hyper-
thyroidism, psychiatric disorders, chronic pain syndrome, 
allergy to ketamine, renal or hepatic insufficiency, history of 
seizure or intracranial hypertension, or drug or alcohol abuse 
in the preceding 6 months were excluded.
Patients were informed about all the study methods and 
educated on the use of the visual analog scale (VAS) before 
surgery. Each patients knew that he/she belonged to one of 
three treatment groups (KI, KS, control). Patients had no 
awareness about which study drug was administered. No 
information about route of drug administration or its type 
(ketamine or placebo) was provided. Patients were informed 
that one drug was being administered to them and that it 
would not have any significant side effects.
Systolic, diastolic, and mean arterial pressure, heart rate, 
respiratory rate, and pulse oximeter oxygen saturation level 
were monitored noninvasively in the operating theater.
The patients were randomized to one of three experimen-
tal groups using random selection of sealed envelopes, with 
30 patients in each group. No premedication was adminis-
tered because the patients were emergency rather than elec-
tive cases. This does not mean that we stopped all medication 
from a specific time point. An anesthesiologist prepared 
the syringes containing either normal saline or the study 
medications for each subject. All medications were 3 mL in 
volume. Patients received either subcutaneous infiltration 
of ketamine (KS) 0.5 mg/kg, intravenous ketamine (KI) 
0.5 mg/kg, or subcutaneous infiltration of normal saline (C) 
3 mL before surgery. The subcutaneous injection was given 
at the incision site.
After induction of anesthesia using 5 mg/kg of thiopental 
sodium, 3 µg/kg fentanyl, and 1.5 mg/kg of succinylcholine, 
the study drugs were administered by a surgeon who was 
not involved in the test sessions. All the surgical   incisions 
were started after 15 minutes of ketamine or saline   injection. 
Time to onset following the intravenous bolus (dosage 
2 mg/kg) was about 30–60 seconds, with the effect lasting 
10–15 minutes. We used a lower dosage of ketamine 
(0.5 mg/kg) so it was probable that the onset of effect was 
delayed. Time of onset of effect for subcutaneous ketamine 
is 5–15 minutes. Therefore, we considered 15 minutes to be 
the time point of achieving the ketamine effect.6
The study drugs were prepared by an anesthesiologist 
who was not involved in data collection. The prepared 
syringes were similar in shape and volume. Subcutaneous 
injection of ketamine or saline in group KS and group C 
was performed by a surgeon who was not aware of the study 
drug. Intravenous administration of ketamine in group KI 
was administered by a resident in anesthesiology who was 
not involved in data collection, which was done by a nurse 
who was not aware of group allocation.
Anesthesia was maintained with 1.2% isoflurane and 
nitrous oxide 50% in oxygen, with atracurium 0.6 mg/kg for 
intraoperative neuromuscular block. Morphine 0.1 mg/kg 
was administered for intraoperative analgesia. At the end 
of surgery, neuromuscular blockade was reversed by intra-
venous neostigmine 0.04 mg/kg and intravenous atropine 
0.02 mg/kg. Consequently, anesthesia was discontinued and 
the tracheal tube removed in the operating room when airway 
reflexes had returned.
Heart rate, pulse oximeter oxygen saturation, systolic 
arterial pressure, diastolic arterial pressure, and mean arterial 
pressure were recorded at 10-minute intervals throughout 
surgery, at the time of arrival in the post-anesthesia care unit 
(PACU), at 10, 20, and 30 minutes thereafter, and 6, 12, 18, 
and 24 hours postoperatively.
After extubation, patients were transferred to the PACU 
where an anesthetist and nurse unaware of the study drug 
administered observed the patients. Pain scores were evalu-
ated by the blinded observer physician at the time of arrival 
in the PACU, and 10, 20, and 30 minutes thereafter using a 
VAS (0–10 cm: 0 = no pain, 10 = the worst pain possible).
During the postoperative period, pain scores were evalu-
ated at hours 6, 12, 18, and 24 by an investigator who was 
blinded to treatment assignment. Sedation state was also 
assessed using a sedation scale (0: awake, 1: drowsy but 
responsive to verbal orders, 2: drowsy but responsive to 
physical stimulus, 3: sleepy but responsive to pain stimulus) 
at the all above-mentioned times.
If the VAS score was .4 cm, 0.4 mg/kg meperidine 
was given intravenously and if the score did not decrease 
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within 10 minutes, an additional 0.2 mg/kg meperidine was 
administered. The total meperidine dose did not exceed a 
maximum of 2 mg/kg in any 4 hours. Time to first need for 
additional meperidine and total meperidine consumption 
were recorded.
Adverse effects (dizziness, allergic reactions, nausea, 
vomiting, and hallucinations) were recorded in the postop-
erative period. Intravenous metoclopramide 0.1 mg/kg was 
administered to patients with vomiting or nausea   lasting 
more than 10 minutes. If required, metoclopramide was 
readministered one hour after the previous injection. 
  Analgesia administration and adverse effects were recorded 
by a physician blinded to the study medication.
Time from induction of anesthesia to discontinuation of 
anesthetic drugs was regarded as the anesthesia duration, and 
the time between discontinuation of nitrous oxide and extuba-
tion was considered to be the extubation time. Time from the 
first surgical incision to the last skin suture was considered to 
be the operation time. Duration of PACU stay was recorded 
using the modified Aldrete scoring system.7
The sample size estimation was based on a power cal-
culation showing that 30 patients per group were necessary 
to achieve 80% power for detecting a 20% difference in 
VAS scoring between group C with groups KS and KI with 
α = 0.05. Data are presented as the mean ± standard devia-
tion or as numbers. Differences among group means were 
compared using one-way analysis of variance and post hoc 
comparisons at various points in time using Bonferroni’s 
type I error rate correction for multiple tests of significance. 
Gender, American Society of Anesthesiologists physical 
status, and complication rates were analyzed by Pearson’s 
Chi-square test and by Fisher’s Exact test when the antici-
pated number was less than five. P , 0.05 was considered 
to be statistically significant. All statistical analyses were 
performed using SPSS software (v 16.0 for Windows; SPSS 
Inc, Chicago, IL).
Results
Ninety patients were enrolled in the study. No patient was 
excluded from the study due to any problem. There was no 
significant difference between the three groups with respect 
to demographic data, duration of surgery, or anesthesia 
(Table 1).
VAS scores were significantly lower upon arrival to the 
PACU, at 10, 20, and 30 minutes thereafter in the KI and KS 
groups compared with group C (P , 0.05, Table 4, Figure 1). 
VAS scores were not significantly different between group 
KI and group KS at these time points. Postoperative VAS 
scores were significantly lower at 6, 12, 18, and 24 hours 
in group KI compared with group C (P , 0.05, Table 4, 
Figure 2). VAS scores were significantly lower at 12, 18, 
and 24 hours after surgery in group KI compared with group 
KS (P , 0.05, Figure 2). In group KS, postoperative VAS 
score was significantly lower at 6 hours (P , 0.05, Figure 2). 
There was no significant difference between the three groups 
in pulse oximeter oxygen saturation, heart rate, and systolic, 
diastolic, and mean arterial pressure at any time points during 
surgery or in the postoperative period.
Median sedation values at any time postoperatively were 
not significantly different between the three groups. Time to 
first rescue analgesia in the postoperative period was signifi-
cantly longer in group KI and group KS compared with group 
C (P , 0.05, Table 2). Postoperative analgesic requirement 
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Figure 1 Postoperative visual analog scale scores at 0, 10, 20, and 30 minutes after 
arrival in the post-anesthesia care unit.
Notes: Data are presented as the mean ± standard deviation. *P , 0.05 versus 
group C.
Abbreviations:  KI,  intravenous  ketamine;  KS,  subcutaneous  ketamine  group;   
C, control.
Table 1   Patient  characteristics  and  duration  of  surgery  and 
anesthesia in three groups
Variable Group KS 
(n = 30)
Group KI 
(n = 30)
Group C 
(n = 30)
Age (years) 30.4 ± 12.0 27.5 ± 8.4 32.9 ± 12.4
gender (female/male) 14/16 12/18 13/17
Weight (kg) 65.4 ± 3.2 67.4 ± 5.2 64.7 ± 7.2
ASA (I/II) 26/4 25/5 24/6
Duration of surgery  
(minutes)
54.2 ± 7.4 56.5 ± 6.0 58.2 ± 7.0
Duration of anesthesia  
(minutes)
66.3 ± 5.5 66.7 ± 5.6 69.0 ± 5.5
Notes: Values are presented as the mean ± standard deviation or number. There 
were no significant differences between three groups.
Abbreviations: KS, subcutaneous ketamine; KI, intravenous ketamine; C, control; 
ASA, American Society of Anesthesiologists.
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effect during the first 24 hours after appendectomy, while 
subcutaneous ketamine had this effect until 6 hours.
All drugs used to induce and maintain anesthesia were 
similar between the three groups, so any significant differ-
ence in some variables, such as the VAS score, could be 
due to our intervention, ie, administering intravenous or 
subcutaneous ketamine. Our results indicate that NMDA 
receptors in the skin and subcutaneous tissue may contribute 
to induction of postoperative hyperalgesia. This conclusion 
is also consistent with the results of previous studies show-
ing that pretreatment with intraplantar injection of NMDA 
and non-NMDA glutamate receptor antagonists attenuates 
the magnitude and time course of lifting and licking behav-
ior produced by formalin injection in the rat paw,8 and that 
peripheral administration of ketamine, an NMDA receptor 
antagonist, inhibits the long-lasting secondary hyperalgesia 
generated by burn injury in humans.9
Elia et al10 showed that when ketamine was adminis-
tered intravenously during anesthesia in adults, it decreased 
postoperative pain intensity for up to 48 hours, decreased 
cumulative 24-hour morphine use, and delayed the time 
to first demand for rescue analgesic. Hazama et al11 also 
showed that preincisional administration of intravenous 
ketamine significantly reduced the postoperative VAS score 
in patients undergoing abdominal hysterectomy compared 
with the control group.
Recently, Sonbaty et al12 showed that peritonsillar infiltra-
tion of a combination of bupivacaine 10 mg and ketamine 
0.5 mg/kg provided efficient postoperative analgesia after 
adenotonsillectomy compared with using each drug alone. 
Also, Safavi et al13 showed that a 2 mg/kg dose of subcuta-
neous infiltration ketamine or 1 mg/kg dose of intravenous 
ketamine given at approximately 15 minutes before surgery 
provided adjunctive analgesia for 24 hours after surgery in 
patients undergoing cholecystectomy surgery. In our study, 
we studied the efficacy of subcutaneous infiltration of ket-
amine 0.5 mg/kg or intravenous ketamine 0.5 mg/kg on 
postoperative pain relief after appendectomy and showed that 
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Figure 2 Visual analog scale scores at 6, 12, 18, and 24 hours after surgery.
Notes: Data are presented as the mean ± standard deviation. *P , 0.05 versus 
group C; †P , 0.05 versus group KS.
Abbreviations:  KI,  intravenous  ketamine;  KS,  subcutaneous  ketamine  group;   
C, control.
Table 2 Postoperative analgesics and antiemetic use and time to tracheal extubation and PACU stay in three groups
Variable Group KS 
(n = 30)
Group KI 
(n = 30)
Group C 
(n = 30)
P value
Time to first analgesic demand (hours) 2.3 ± 0.7* 2.8 ± 0.9* 1.5 ± 0.5 0.000
Postoperative analgesic requirement (mg) 33.8 ± 15.2* 31.0 ± 8.9* 69.2 ± 30.2 0.000
Duration of PACU stay (minutes) 29.7 ± 2.2 30.4 ± 3.8 29.8 ± 3.3 0.655
Time to tracheal extubation (minutes) 15.1 ± 1.0 15.2 ± 1.1 14.7 ± 1.5 0.275
Postoperative antiemetic requirement (mg) 0.17 ± 0.4 0.13 ± 0.3 0.1 ± 0.3 0.756
Notes: Values are presented as the mean ± standard deviation. *P , 0.05 versus group C. 
Abbreviations: KS, subcutaneous ketamine; KI, intravenous ketamine; C, control; PACU, post-anesthesia care unit.
was also significantly lower in group KI and group KS 
compared with group C (P , 0.05, Table 2). There were no 
significant differences in the duration of stay in the PACU, 
time to tracheal extubation, and postoperative antiemetic 
requirements between the three groups (Table 2).
The incidence of adverse effects was not significantly 
different between the three groups (Table 3). There was no 
patient with emergent delirium, hallucinations, or nightmares 
in any of the groups.
No significant hypotension (systolic blood pressure 
less than 90 mmHg) or bradycardia (heart rate less than 
50 beats per minute) was noted throughout surgery or 
postoperatively.
Discussion
Our results showed that preincisional treatment with intra-
venous or subcutaneous infiltration of ketamine, a NMDA 
receptor antagonist, reduced postoperative pain scores com-
pared with preincisional infiltration of normal saline solu-
tion in patients undergoing appendectomy, and had no side 
effects. Our results also confirmed that a single small dose of 
ketamine administered intravenously delays the first request 
for analgesic and produces a significant pethidine-sparing 
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a lower dosage of intravenous ketamine can also significantly 
decrease analgesic use until 24 hours. Using subcutaneous 
ketamine 0.5 mg/kg in our study had a significant pain-
reducing effect until 6 hours after surgery that could be due 
to use of a low dosage of ketamine.
It seems probable that the antinociceptive effects of 
ketamine occur as a result of blockage of NMDA receptors 
located on primary afferent axons in the skin. Carlton and 
Coggeshall14 showed that NMDA and non-NMDA gluta-
mate receptors are present on primary afferent axons and 
are increased after onset of inflammation. Moreover, release 
of glutamate into peripheral tissues is increased after injury 
and inflammation.15
The stimulation of NMDA and non-NMDA glutamate 
receptors by glutamate may induce hyperalgesia and allo-
dynia which is interpreted as pain.16,17 Therefore, an expla-
nation for our results may be that ketamine binding to the 
NMDA receptors might inhibit glutamate-induced activation 
of NMDA receptors on primary afferents in the skin, which 
consequently decreases peripheral nociceptive input into the 
spinal cord and central sensitization of the dorsal horn.
The objectives of pre-emptive analgesia are, firstly, to 
inhibit or lessen the development of any “memory” of pain 
stimulus in the central nervous system and, secondly, to lessen 
analgesic requirements as a consequence.18 The pre-emptive 
effect of preincisional administration of intravenous ketamine 
on the inflammatory response to surgery could explain the 
long-lasting effect of ketamine on decreasing postoperative 
pain observed in group KI at 24 hours.19,20
The local anesthetic properties of ketamine have been 
shown in a previous report.21 Tverskoy et al22 investigated 
the analgesic efficacy of bupivacaine with ketamine infil-
tration during inguinal hernia incision, and concluded that 
the duration of local anesthesia was doubled via peripheral 
mechanisms. Moreover, it was shown that intravenous ket-
amine produced adequate regional anesthesia in a sample 
of volunteers.22,23 The pre-emptive blockade of initial 
nociceptive afferent input to the spinal cord may inhibit 
the development of long-term changes in the excitability 
of central neurons and consequently produce long-lasting 
antinociceptive effects.24
The analgesic effect of NMDA antagonism has been 
demonstrated to be relatively brief when administered after 
pain stimulation. This is probably due to failure to inhibit 
the maintenance of pain behavior (because peripheral or 
central sensitization has developed earlier).24 Therefore, it is 
likely that prevention of the original neural activity by local 
infiltration of ketamine during induction of pain behavior 
may inhibit the preservation of pain behavior.
An additional theory to describe the analgesic effect of 
small doses of ketamine may be the synergistic or additive 
interaction among opioids, which reveals activation of the 
NMDA receptors25 and NMDA antagonists. One of the mecha-
nisms of severe postoperative pain which leads to the need for 
increasingly higher doses of opioids in postoperative patients is 
tolerance. It seems that small doses of ketamine work specifi-
cally to inhibit tolerance and pain sensitization.26,27
In conclusion, preincisional intravenous administration 
of low-dose ketamine provides analgesia for 24 hours after 
Table 3 Incidence of adverse effects in the three groups
Variable Group KS 
(n = 30)
Group KI 
(n = 30)
Group C 
(n = 30)
nausea 3 1 1
Vomiting 2 3 2
Dizziness 1 1 0
Notes: Values are presented as numbers. There were no significant differences 
between three groups.
Abbreviations: KS, subcutaneous ketamine; KI, intravenous ketamine; C, control.
Table 4 Postoperative visual analog scale scores at different time intervals in the three groups
Variable Group KS 
(n = 30)
Group KI 
(n = 30)
Group C 
(n = 30)
P value
VAS after arrival in PACU (minutes)
  VAS 0 1.2 ± 0.4* 1.1 ± 0.6* 4.9 ± 0.8 0.000
  VAS 10 0.9 ± 0.9* 0.8 ± 0.5* 4.1 ± 0.8 0.000
  VAS 20 0.9 ± 0.5* 1.3 ± 0.7* 3.5 ± 0.7 0.000
  VAS 30 1.3 ± 0.7* 1.0 ± 0.3* 3.8 ± 0.5 0.000
Postoperative VAS on ward (hours)
  VAS 6 7.3 ± 0.8* 7.2 ± 1.3* 7.9 ± 0.0 0.002
  VAS 12 6.4 ± 0.8 5.4 ± 0.9*,† 6.7 ± 0.5 0.000
  VAS 18 5.1 ± 1.3 3.5 ± 1.2*,† 5.5 ± 0.6 0.000
  VAS 24 4.0 ± 1.5 1.7 ± 0.9*,† 4.4 ± 0.7 0.000
Notes: Data are presented as the mean ± standard deviation. *P , 0.05 versus group C; †P , 0.05 versus group KS.
Abbreviations: KS, subcutaneous ketamine; KI, intravenous ketamine; C, control; PACU, post-anesthesia care unit; VAS, visual analog scale score.
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surgery without significant side effects in patients undergoing 
appendectomy. This conclusion holds true for subcutaneous 
administration of ketamine for the first 6 hours after surgery. 
Whether this is due to antagonism of peripheral NMDA 
receptors, local anesthesia, or other unknown effects of 
ketamine, remains unidentified. It is unknown if a higher 
dosage of ketamine can be advantageous or not. However, 
our results are interesting in light of the potential clinical 
application of this agent in appendectomy and potentially 
other types of surgery.
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